A breakdown of recent survey results revealing which benefits employers plan to keep and what they are looking to add in 2025.
Healthcare costs are on the rise, but most employers don’t plan to cut their benefits, according to the results of a recent survey by Mercer, a global consulting firm. The results of their Survey on Health and Benefit Strategies for 2025 were published yesterday.
Nearly 700 organizations participated in this survey, which was conducted earlier this year from March 21 to April 12.
Total healthcare benefit cost has increased 3% annually from 2013 to 2022, but in 2023, the cost jumped to 5.2% partly due to medical inflation. It’s estimated that costs in 2024 will be similar. Prescription drug costs rose 8.6% per employee in 2023.
Despite this, 69% of employers are still committed to boosting affordability in the next few years.
Here are some of the ways they plan to do that:
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Published: November 25th 2024 | Updated: November 25th 2024CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
Read More